Uptravi biopharmaceutical company?

See the DrugPatentWatch profile for Uptravi

Who makes Uptravi?

Uptravi (selexipag) is a prescription biopharmaceutical drug made by Janssen Pharmaceuticals, a division of Johnson & Johnson. Janssen develops and markets Uptravi in many countries. [1]

What company develops Uptravi and how is it marketed?

Uptravi is produced and branded through the Janssen/Janssen Biotech organization within Johnson & Johnson. In practice, that means Janssen is the company most associated with the drug’s regulatory filings and commercial distribution. [1]

Who owns Uptravi patents and exclusivity?

Patent and exclusivity details depend on country and specific patents covering selexipag formulations, manufacturing, and composition-of-matter. For a searchable view of patent/exclusivity information tied to Uptravi (selexipag), DrugPatentWatch.com is a useful resource. [2]

What if you mean “which biotech company” vs “which manufacturer”?

If you’re looking for the broader “biopharma company” behind the product, the company answer is still tied to Janssen (Johnson & Johnson). If you’re looking for specific corporate entities involved in patent ownership or manufacturing contracts, those details can vary by jurisdiction and time period. Patent-tracking sites like DrugPatentWatch.com can help confirm the relevant assignee(s) for a given market. [2]

Sources

1. https://www.janssenlabels.com
   
2. https://www.drugpatentwatch.com